Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip H. Elsinga

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2014
In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitutionWillem-Jan Kuik, Ido P Kema, Adrienne H Brouwers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammationInês F Antunes, Janine Doorduin, Hidde J Haisma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2002
Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancerRemge M Pieterman, Tjin H Que, Philip H Elsinga, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|September 9, 2014
Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspectiveJoel Aerts, James R Ballinger, Martin Behe, et al.
Psychopharmacology|July 11, 2015
Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active dosesKristoffer Sahlholm, Jurgen W A Sijbesma, Bram Maas, et al.
Molecular Imaging|April 28, 2011
In vivo imaging of apoptosis in oncology: an updateChristel Vangestel, Marc Peeters, Gilles Mees, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2013
In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imagingAnna A Rybczynska, Marco de Bruyn, Nisha K Ramakrishnan, et al.
Medicinal Research Reviews|January 28, 2017
Potential Therapeutic Applications of Adenosine A<sub>2A</sub> Receptor Ligands and Opportunities for A<sub>2A</sub> Receptor ImagingAren van Waarde, Rudi A J O Dierckx, Xiaoyun Zhou, et al.
Amino Acids|July 27, 2012
Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancerZilin Yu, Giuseppe Carlucci, Hildo J K Ananias, et al.
Nuclear Medicine and Biology|May 28, 2013
Synthesis of [18F]RGD-K5 by catalyzed [3 + 2] cycloaddition for imaging integrin αvβ3 expression in vivoLeila Mirfeizi, Joe Walsh, Hartmuth Kolb, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2014
In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitutionWillem-Jan Kuik, Ido P Kema, Adrienne H Brouwers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammationInês F Antunes, Janine Doorduin, Hidde J Haisma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2002
Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancerRemge M Pieterman, Tjin H Que, Philip H Elsinga, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|September 9, 2014
Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspectiveJoel Aerts, James R Ballinger, Martin Behe, et al.
Psychopharmacology|July 11, 2015
Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active dosesKristoffer Sahlholm, Jurgen W A Sijbesma, Bram Maas, et al.
Molecular Imaging|April 28, 2011
In vivo imaging of apoptosis in oncology: an updateChristel Vangestel, Marc Peeters, Gilles Mees, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2013
In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imagingAnna A Rybczynska, Marco de Bruyn, Nisha K Ramakrishnan, et al.
Medicinal Research Reviews|January 28, 2017
Potential Therapeutic Applications of Adenosine A<sub>2A</sub> Receptor Ligands and Opportunities for A<sub>2A</sub> Receptor ImagingAren van Waarde, Rudi A J O Dierckx, Xiaoyun Zhou, et al.
Amino Acids|July 27, 2012
Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancerZilin Yu, Giuseppe Carlucci, Hildo J K Ananias, et al.
Nuclear Medicine and Biology|May 28, 2013
Synthesis of [18F]RGD-K5 by catalyzed [3 + 2] cycloaddition for imaging integrin αvβ3 expression in vivoLeila Mirfeizi, Joe Walsh, Hartmuth Kolb, et al.
Pageof 17